The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
R

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer and Enfortumab in Metastatic Bladder Cancer

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
0 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Genitourinary
11:59
KU Hematology & Medical Oncology Review 2019

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic …

Feat. R. Parikh
11:41
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal…

Feat. R. Parikh